Tartrate-Resistant Acid Phosphatase [kyselá fosfatasa rezistentní k tartarátu]
- Terms
-
kyselá fosfatasa V
kyselá fosfatáza V
tartarát rezistentní fosfatáza
tartarát rezistentní kyselá fosfatáza
TRAcP
uteroferin
uteroferrin
-
Acid Phosphatase V
AcPase V
Tartrate-Resistant Acid Phosphatase Type 5
TRAcP
TRAP Type 5 AcPase
Type 5 Acid Phosphatase
Uteroferrin
One of several acid phosphatases in humans, other mammals, plants, and a few prokaryotes. The protein fold of tartrate-resistant acid phosphatase (TRAP) resembles that of the catalytic domain of plant purple acid phosphatase and other serine/threonine-protein phosphatases that also contain a metallophosphoesterase domain. One gene produces the various forms which include purple acid phosphatases from spleen and other tissues. Tartrate-resistant acid phosphatase is a biomarker for pathological states in which it is over-expressed. Such conditions include GAUCHER DISEASE; HODGKIN DISEASE; BONE RESORPTION; and NEOPLASM METASTASIS.
- DUI
- D000071681 MeSH Browser
- CUI
- M0246521
- History note
- 2017 (1995)
- Public note
- 2017; TARTRATE-RESISTANT ACID PHOSPHATASE was indexed under ACID PHOSPHATASE and ISOENZYMES 1995-2016
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 3
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0